Skip to main content

Table 4 ROC analysis of plasma NGAL in non-CKD and CKD patients

From: Plasma neutrophil gelatinase-associated lipocalin in acute kidney injury superimposed on chronic kidney disease after cardiac surgery: a multicenter prospective study

Non-CKD

AUC-ROC

Cutoff (Youden)

Sensitivity (Youden)

Specificity (Youden)

Cutoff (95% sensitivity)

Specificity (95% sensitivity)

Cutoff (95% specificity)

Sensitivity (95% specificity)

(n = 78)

(95% CI)

(ng/ml)

  

(ng/ml)

 

(ng/ml)

 

pre

0.69

73

65%

75%

52

33%

298

15%

(0.55 to 0.81)

0 h

0.76

102

65%

90%

49

33%

147

23%

(0.60 to 0.87)

2 h

0.67

142

45%

90%

48

19%

220

13%

(0.50 to 0.80)

4 h

0.76

72

90%

60%

49

28%

226

15%

(0.60 to 0.86)

12 h

0.73

90

70%

76%

48

26%

226

15%

(0.56 to 0.85)

24 h

0.73

91

75%

66%

47

14%

240

20%

(0.57 to 0.84)

36 h

0.63

113

55%

72%

44

10%

376

5%

(0.46 to 0.77)

60 h

0.62

124

55%

77%

35

1%

284

20%

(0.43 to 0.77)

CKD

AUC-ROC

Cutoff (Youden)

Sensitivity (Youden)

Specificity (Youden)

Cutoff (95% sensitivity)

Specificity (95% sensitivity)

Cutoff (95% specificity)

Sensitivity (95% specificity)

(n = 68)

(95% CI)

(ng/ml)

  

(ng/ml)

 

(ng/ml)

 

pre

0.71

472

33%

100%

68

23%

341

33%

(0.56 to 0.82)

0 h

0.75

111

76%

63%

77

32%

233

30%

(0.61 to 0.85)

2 h

0.75

233

52%

94%

59

16%

241

44%

(0.61 to 0.85)

4 h

0.74

163

70%

69%

69

16%

286

40%

(0.60 to 0.84)

12 h

0.72

340

42%

97%

71

19%

322

42%

(0.58 to 0.83)

24 h

0.77

241

59%

85%

70

24%

363

43%

(0.63 to 0.87)

36 h

0.71

373

45%

94%

71

11%

379

44%

(0.56 to 0.82)

60 h

0.66

537

31%

97%

62

10%

432

31%

(0.51 to 0.78)

  1. AUC-ROC, area under the curve operating characteristic curves; CI, confidence interval; CKD, chronic kidney disease; NGAL, neutrophil gelatinase-associated lipocalin.